Full-Time

MRI Technologist

Updated on 8/1/2026

Akumin

Akumin

1,001-5,000 employees

Outsourced radiology and oncology services

No salary listed

Port St. Lucie, FL, USA

In Person

Local travel and work at several locations may be required.

Category
Medical, Clinical & Veterinary (1)
Required Skills
Customer Service

Get referred to Akumin

See people who can refer or advise you

Requirements
  • A High School Diploma or equivalent experience is required.
  • The candidate must hold ARRT (R), ARRT (MR), or ARMRIT as allowable by contract in lieu of ARRT.
  • A state license is required if applicable.
  • CPR Certification is required.
  • A valid state driver’s license is required if applicable.
  • Technologists registered in other modalities must have three months of supervised MRI clinical scanning experience or be currently enrolled for more than six months in an accredited MRI training program.
  • No experience is required for MR-registered technologists RT(MR) or ARMRIT.
  • The candidate must be able to work at several locations.
  • Strong customer service skills are required.
  • Organizational and multitasking skills are required.
  • Basic knowledge of computer applications and programs is required.
  • COVID-19 vaccination may be a condition of employment.
  • Local travel may be required.
Responsibilities
  • Ensure patient safety, including prescreening for contraindications, using aseptic injection technique, and overseeing remote MRI Technologist Assistants when required.
  • Produce high-quality diagnostic images and operate multiple MRI systems when required.
  • Use all communication channels to address concerns, solve problems, and resolve conflict.
  • Communicate effectively with customers and radiologists.
  • Train and orient new technologists, Patient Coordinators, and MRI Technologist Assistants on site or remotely.
  • Perform other duties as assigned.
Desired Qualifications
  • An Associate’s Degree or equivalent experience is preferred.
  • Registry in Magnetic Resonance by the American Registry of Radiologic Technologists is preferred.
  • One year of Magnetic Resonance Imaging experience is preferred.

Akumin provides outsourced radiology and oncology services to hospitals, health systems, and physician groups across the United States through a network of fixed-site outpatient imaging centers and outpatient radiology and oncology services. It operates imaging centers and partners with healthcare facilities to offer diagnostic imaging, interpretation, and related outpatient services at scale across 47 states. Its nationwide focus on outsourced radiology and oncology allows hospitals to access imaging and cancer-care resources without maintaining all services in-house. The company aims to be a trusted partner for healthcare providers by delivering reliable, scalable imaging and cancer-care services that improve patient access to diagnostics and treatment.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Plantation, Florida

Founded

1997

Get referred to Akumin

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • The New Berlin facility supports higher-volume production and faster clinic deployment.[2]
  • More than 800 hospital and physician-group partners provide a large cross-sell base.[2]
  • Turnkey mobile oncology and radiology units address underserved communities and capacity shortages.[2]

What critics are saying

  • New plant capacity hurts returns if AXIS orders lag production growth.[2]
  • Large hospital partners can pressure pricing, renewals, and outsourcing volumes.[2]
  • Another operating miss after Chapter 11 could trigger financing stress and restructuring risk.[5]

What makes Akumin unique

  • MHI with CGS Premier scales Akumin AXIS relocatable imaging and oncology clinics.[2]
  • Akumin AXIS units arrive self-contained with MRI, PET, or LINAC installed.[2]
  • Stonepeak became Akumin's 100% owner in February 2024 after bankruptcy.[5]

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

31%

1 year growth

31%

2 year growth

31%
Innovate Healthcare
Jan 5th, 2026
Akumin secures $154M investment and restructures debt to extend repayment timeline to 2031

Akumin Inc. has secured $154 million in new capital from Stonepeak, an alternative investment firm, to support long-term growth of its imaging and radiation oncology services. The company is also restructuring its debt with noteholders representing over 95% of its outstanding senior secured notes. Under the agreement, Akumin's existing debt will be exchanged for new senior secured notes due in 2031, carrying a 9.75% interest rate that can drop to 8.75% if certain credit targets are met. The company's revolving credit facility, with roughly $119 million outstanding, will convert into preferred equity or move to a lower-priority position. The restructuring follows Akumin's recent launch of new offerings at the Radiological Society of North America meeting, including its Axis Drop Trailer and relocatable MRI suites.

Cantech Letter
Oct 23rd, 2023
Akumin likely won’t get a better offer than Stonepeak, Clarus says

The deal from private equity firm Stonepeak to acquire Akumin likely won’t be topped, says Clarus Securities analyst Noel Atkinson.

PR Newswire
Oct 20th, 2023
Akumin Inc. Reaches Agreement With Stonepeak To Become A Private Company

Financial restructuring to fortify balance sheet and provide liquidity runway for next stage of growthApprovals received from key stakeholders across capital structure; transaction will be implemented through prepackaged court-supervised process; Expected to obtain court approval within the next 45 daysBusiness will continue to operate as usual without interruption; trade creditors, employees, and other partners expected to continue to be paid in ordinary coursePLANTATION, Fla., Oct. 20, 2023 /PRNewswire/ - Akumin Inc. ("Akumin" or the "Company") (NASDAQ: AKU) (TSX: AKU) announced today that it has reached an agreement with Stonepeak, a leading alternative investment firm specializing in infrastructure and real assets, and the Company's stakeholders on the terms of a financial restructuring that will substantially improve the Company's balance sheet and provide ample liquidity to position Akumin for future success. The contemplated transaction will result in Akumin no longer being publicly listed.To effect the transaction in a timely and efficient manner, the Company and certain of its subsidiaries will commence prepackaged chapter 11 cases in the Southern District of Texas. The Company expects to obtain court approval of the transaction within the next 45 days and complete the transaction after receiving certain regulatory approvals. Throughout the process, Akumin's operations are expected to continue as normal